ASX
Paradigm Biopharmaceuticals Limited
PAR:ASX•Healthcare
Sensitive ASX Announcement
PRESENTATION OF PHASE 2 CLINICAL TRIAL RESULTS
Published: 18/12/18, 08:48am (AEST)•16 pages